Prostate Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q4 | 21.0% | 0.602 | Q2 | 67.7% |
| 2024 | 2.0 | Q3 | 29.1% | 0.560 | Q2 | 66.1% |
| 2023 | 2.3 | Q3 | 36.5% | 0.305 | Q3 | 49.4% |
| 2022 | 4.2 | 63.9% | 0.364 | Q3 | 56.4% | |
| 2021 | — | 25.2% | 0.321 | Q3 | 53.4% | |
| 2020 | — | — | 0.377 | Q3 | 57.5% | |
| 2019 | — | — | 0.703 | Q2 | 77.0% | |
| 2018 | — | — | 0.877 | Q2 | 80.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2090-312X
ISSN
2090-3111
country
GBcoverage
2010-2026